Primerica
PRI NYSEΒ· Life & Health Insurance
Last close Β· Oct 27, 2026
$277.55
KIRA Β· Stoqlyβs AI analyst, in plain words
- Primerica had $3.3B of revenue in fiscal 2025, up 6.6% on the year before. Over five years, revenue changed +8.2% a year on average.
- Primerica made $751M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 19.6% a year.
- Primerica returned $586M to shareholders in fiscal 2025. The diluted share count fell 4.4%.
- Primerica has $160M more cash than debt.
Market cap
$8.7B
P/E
11.2x
Revenue
$3.3B
Net income
$751M
Free cash flow
β
Operating margin
β
Primerica in 30 seconds Β· fiscal 2025
Are sales growing?
+6.6%
Yes. Sales grew 6.6% last year.
Does it make a profit?
22.8%
Yes. It keeps 22.8% of every sale as profit.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How is the share priced?
11.2x
One share costs 11.2 times its yearly profit per share. Typical for its sector: 13.7x.
What Primerica does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Legal name
- Primerica, Inc.
- CIK
- 0001475922
Primerica Β· PRI
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $2.7B | $2.7B | $2.7B | $3.1B | $3.3B |
| Revenue growth | 22.2% | β1.9% | 3.4% | 12.4% | 6.6% |
| Gross margin | 98.1% | 97.4% | 98.0% | β | β |
| Net income | $477M | $472M | $577M | $471M | $751M |
| Net margin | 17.6% | 17.8% | 21.0% | 15.2% | 22.8% |
| Diluted EPS | $11.99 | $12.33 | $15.94 | $13.71 | $22.91 |
| Cash | |||||
| Cash from operations | $657M | $758M | $693M | $862M | $901M |
| Dividends paid | $74.6M | $83.8M | $93.7M | $113M | $136M |
| Share buybacks | $18.8M | $356M | $375M | $425M | $450M |
| Share count change | β1.3% | β3.9% | β5.5% | β5.1% | β4.4% |
| Debt and strength | |||||
| Cash and short-term investments | $478M | $559M | $594M | $688M | $756M |
| Debt incl. finance leases | $593M | $594M | $594M | $596M | $596M |
| Shareholders' equity | $925M | $2.0B | $2.1B | $2.3B | $2.4B |
| Net debt / EBITDA | 0.2x | 0.0x | 0.0x | β0.1x | β0.2x |
| Interest coverage | 22.0x | 27.4x | 30.0x | 39.8x | 43.2x |
| Returns and quality | |||||
| Return on capital | β | 37.1% | 29.6% | 34.9% | 34.5% |
| Return on equity | 34.6% | 31.9% | 28.2% | 21.8% | 31.9% |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$4.5M
5 insiders
Of sales under plans
93%
$4.2M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Primerica Β· PRI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each companyβs latest fiscal year. Fiscal years end in different months, so periods donβt line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Primerica PRI | $8.7B | 6.6% | β | β | 34.5% | 11.2x | β |
| CNO Financial Group CNO | $5.2B | 0.9% | 12.3% | β | β | 18.7x | β |
| Globe Life GL | $12.4B | 3.7% | β | 20.9% | 16.0% | 10.4x | β |
| Brighthouse Financial BHF | $2.6B | 43.2% | β | β | β | 3.6x | β |
| Unum UNM | $14.3B | 1.5% | β | 4.3% | 7.6% | 20.8x | β |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $277.55 a share, the company is worth $8.7B: 11.2 times its earnings of the last four quarters.
Primerica grew sales faster than 3 of its 4 similar companies. Its P/E is higher than 2 of 4.
Source: SEC EDGAR XBRL filings (CIK 0001475922). Data updated October 11, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
